Russo, Cristina
Cibella, Fabio
Caponnetto, Pasquale
Campagna, Davide
Maglia, Marilena
Frazzetto, Evelise
Mondati, Enrico
Caruso, Massimo
Polosa, Riccardo
Article History
Received: 13 May 2015
Accepted: 20 November 2015
First Online: 5 January 2016
Competing interests
: None of the authors have any competing financial interests to declare, with the exception of RP. RP has received lecture fees and research funding from Pfizer and GlaxoSmithKline, manufacturers of stop smoking medications. He has also served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, Arbi Group Srl (the Italian distributor for Categoria electronic cigarettes) and ECITA (Electronic Cigarette Industry Trade Association, in the UK). Lectures fees from a number of European electronic cigarette industry and trade associations (including FIVAPE in France and FIESEL in Italy) were directly donated to vaper advocacy organizations. He is currently scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti Smoking League).